Trial · NCT07907770
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | 1. Judgment error | Baseline (single session, up to 2 hours) | Calculated as the absolute difference (in cm) between the estimated maximum obstacle height and the actual maximum height successfully crossed |
| Primary | 2. Normalized Estimated Maximum Obstacle Crossing Height | Baseline (single session, up to 2 hours) | The estimated maximum obstacle height the participant believes they can cross, normalized to the participant's leg length |
| Secondary | 1. Perceptual Error type (Over-estimation / Under-estimation) | Baseline (single session, up to 2 hours) | Categorized as over-estimation (actual performance \< estimated) or under-estimation (actual performance \> estimated) |
| Secondary | 2. Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III | Baseline (single session, up to 2 hours) | The evaluator assesses components such as bradykinesia, tremor, posture, and muscle rigidity. Higher scores indicate greater motor impairment. Assessed only in participants with Parkinson's disease |
| Secondary | 3. Levodopa Equivalent Dose (LED) | Baseline (single session, up to 2 hours) | A calculated value reflecting the weighted medication dosage for Parkinson's disease, serving as an indicator of disease severity. Assessed only in the Parkinson's disease group. |
| Secondary | 4. Timed Up and Go (TUG) Test | Baseline (single session, up to 2 hours) | The time (in seconds) it takes to rise from a chair, walk 3 meters, turn, return, and sit down is measured. Faster times indicate better functional mobility and lower fall risk |
| Secondary | 5. NeuroTrax™ - Global Cognitive Score (GCS) | Baseline (single session, up to 2 hours) | Assessed using the NeuroTrax™ computerized cognitive testing battery. Participants perform tasks testing attention, visuospatial processing, and executive functions. Results yield a GCS, where higher scores indicate better cognitive function |
| Secondary | 6. Self-Awareness of Falls Risk Measure (SAFRM) | Baseline (single session, up to 2 hours) | A measure assessing self-awareness of falls risk, consisting of identical patient and clinician versions across three sub-scales: Intellectual (15 items), Emergent (6 items, completed immediately after the Timed Up and Go test), and Anticipatory (10 items). The awareness score is calculated as the sum of the patient's scores minus the sum of the clinician's scores. A score of 0 indicates good awareness. A positive score indicates the patient overestimates their ability or underestimates the risk, while a negative score indicates the patient underestimates their ability or overestimates the risk |
| Secondary | 7. Geriatric Depression Scale (GDS-15) | Baseline (single session, up to 2 hours) | A 15-item questionnaire. Scores range from 0 to 15, with scores greater than 5 indicating a probability of depression |
| Secondary | 8. Activities-specific Balance Confidence (ABC) Scale | Baseline (single session, up to 2 hours) | Participants rate their confidence in performing daily activities without losing balance from 0% (no confidence) to 100% (complete confidence). The total score is the average of all items, with higher scores indicating greater confidence and less fear of falling |
| Secondary | 9. Charlson Comorbidity Index (CCI) | Baseline (single session, up to 2 hours) | Quantified based on number and type of comorbidities as recorded in the participant's medical records. Higher scores indicate a heavier burden of comorbid conditions |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07907770/registered